MULTIPLE ORAL DOSES (ABT-229)/POSTPRANDIAL DIGESTIVE SYMPTOMS/DYSPEPSIA

功能性或非溃疡性消化不良是一种上消化道疾病，其特征是持续或反复出现的上腹部不适症状，不能归因于结构或生化异常。 这种疾病在大约25%的人口中普遍存在。 本研究是一项II期、随机、双盲、安慰剂对照、多中心研究，目的是评价一种新型促动力剂（ABT-229）治疗非溃疡性消化不良患者的疗效。

Functional or non ulcer dyspepsia is a upper gastrointestinal disorder that is characterized by persistent or recurrent symptoms of upper abdominal discomfort, which can not be attributed to structural or biochemical abnormalities. The disorder is prevalent in approximately 25% of the population. This study is a phase II randomized double blind placebo-controlled multi center study of a new pro-motility agent (ABT-229) in patients with non ulcer dyspepsia.